AAREYDRUGS
Start SIP
Invest Now
Start SIP in AAREYDRUGS
Performance
- Low
- ₹61
- High
- ₹64
- 52 Week Low
- ₹31
- 52 Week High
- ₹100
- Open Price₹61
- Previous Close₹63
- Volume139,856
- 50 DMA₹73.22
- 100 DMA₹74.34
- 200 DMA₹70.20
Investment Returns
- Over 1 Month -8.19%
- Over 3 Month -28.44%
- Over 6 Month -4.7%
- Over 1 Year + 23.77%
Smart Investing Starts Here Start SIP with Aarey Drugs & Pharmaceuticals for Steady Growth!
Aarey Drugs & Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 49.8
- PEG Ratio
- -1.2
- Market Cap Cr
- 178
- P/B Ratio
- 1.2
- Average True Range
- 3.56
- EPS
- 1.26
- Dividend Yield
- 0
- MACD Signal
- -3.13
- RSI
- 32.73
- MFI
- 61.6
Aarey Drugs & Pharmaceuticals Financials
Aarey Drugs & Pharmaceuticals Technicals
EMA & SMA
Current Price
₹62.90
+
0.17
(0.27%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹67.80
- 50 Day
- ₹73.22
- 100 Day
- ₹74.34
- 200 Day
- ₹70.20
Resistance and Support
62.86
- R3 67.50
- R2 66.00
- R1 64.36
- S1 61.22
- S2 59.72
- S3 58.08
Aarey Drugs & Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-13 | Quarterly Results | |
| 2025-08-13 | Quarterly Results | |
| 2025-05-30 | Audited Results | |
| 2025-02-14 | Quarterly Results | |
| 2024-12-04 | To consider Fund Raising |
Aarey Drugs & Pharmaceuticals F&O
About Aarey Drugs & Pharmaceuticals
- NSE Symbol
- AAREYDRUGS
- BSE Symbol
- 524412
- Chairman & Managing Director
- Mr. Mihir R Ghatalia
- ISIN
- INE198H01019
Similar Stocks to Aarey Drugs & Pharmaceuticals
Aarey Drugs & Pharmaceuticals FAQs
Aarey Drugs & Pharmaceuticals share price is ₹62 As on 20 January, 2026 | 17:04
The Market Cap of Aarey Drugs & Pharmaceuticals is ₹178.3 Cr As on 20 January, 2026 | 17:04
The P/E ratio of Aarey Drugs & Pharmaceuticals is 49.8 As on 20 January, 2026 | 17:04
The PB ratio of Aarey Drugs & Pharmaceuticals is 1.2 As on 20 January, 2026 | 17:04
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.